Docetaxel combination produces 2-year survival advantage in NSCLC patients
- PMID: 11780700
Docetaxel combination produces 2-year survival advantage in NSCLC patients
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
